University of Thessaly (UTH)
Μελέτη της έκφρασης των γονιδίων EGFR, RAS που εμπλέκονται στο μονοπάτι μεταγωγής σήματος του υποδοχέα του επιδερμικού αυξητικού παράγοντα σε συμπαγείς όγκους
Abstract
dc:descriptionColorectal cancer (CRC) is the third most commonly diagnosed type of cancer and the fourth most common cause of cancer related death worldwide. Nowadays several clinical studies have highlighted the predictive role of gene alterations involved in the EGFR pathway. In this study we investigated the presence of KRAS / BRAF mutations and their correlation with the clinical-histopathological parameters in 322 patients with colon cancer. In addition, we collected fresh paired tumor and normal tissue from 50 patients and investigated the expression level of KRAS and EGFR gene, in mRNA transcripts using the method of real time polymerase chain reaction. Then the correlation between expression levels and various clinicopathological parameters was examined.Our study showed that frequency and distribution of KRAS and BRAF mutations in Greek population are similar to that described in previous studies. G>A transition at codon 12 of KRAS gene showed a statistically significant correlation with the absence of lymph node metastases (p<0.05). Instead, G>C transversion in the same codon, showed statistically significant correlation with the presence of lymph node metastases (p<0.005). KRAS/ BRAF p.V600E mutations were correlated with tumour location in the right colon compared to those located in the left colon and rectum (p<0.05, p<0.005 respectively). There was statistically significant correlation between the absence of KRAS mutations and high grade tumors (p<0.005).The presence of BRAF p.V600E mutation was associated with high grade tumors (p<0.005) and increased number of lymph node metastasis (N2), in patients with metastatic disease (p<0.05).According to absolute quantification method mRNA expression of KRAS/EGFR genes was higher in tumour compared to normal tissue and this finding was statistically significant (p<0.05). Among patients with lymph node involvement, mRNA expression of KRAS gene was significantly associated with the number of lymph node metastasis. We also found a positive correlation between increased mRNA expression of the EGF-receptor and the presence of the KRAS gene mutations, but not proved to be statistically significant, possibly due to small number of patients.In summary our findings confirm that tumours with right location follow different pathway of carcinogenesis compared to left located tumours. Moreover, the presence of KRAS/BRAF mutations was associated with aggressive behavior and worse survival of patients with colorectal adenocarcinomas. KRAS mRNA expression could be a candidate biomarker for assessing invasive capacity of the tumor and possible recurrence of the disease. Increased mRNA expression of the EGF-receptor in patients with KRAS mutations indicates the presence of other regulatory mechanisms beyond KRAS mutations. Assessment of expression levels may serve as a useful biomarker of prognostic and predictive value in the future.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kapatou, Kasiani-Anastasia
- Καπάτου, Κασιανή-Αναστασία
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38332